Sarah Shigdar

Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia.

Cytochemical characterisation of the leucocytes and thrombocytes from Murray cod (Maccullochella peelii peelii, Mitchell).

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.

Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer.

RNA aptamers targeting cancer stem cell marker CD133.

The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer.

Inflammation and cancer stem cells.

Aptamers as theranostic agents: modifications, serum stability and functionalisation.

Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.

Cancer stem cells: A contentious hypothesis now moving forward.

Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.

Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model.

Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.

Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.

Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.

Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.

Cancer stem cell targeted therapy: progress amid controversies.

Application of Aptamers in Histopathology.

EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model.

The Application of Aptamers for Immunohistochemistry.

Challenges and opportunities for siRNA-based cancer treatment.

Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.

Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity.

Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases.

What potential do aptamers hold in therapeutic delivery?

Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells.

Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.

Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.

Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.

Aptamers as potential therapeutic agents for ovarian cancer.

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.

Radiolabelled Aptamers for Theranostic Treatment of Cancer.

Aptamer-Based Diagnostics and Therapeutics.

Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications?

Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells.

Antibodies, Nanobodies, or Aptamers-Which Is Best for Deciphering the Proteomes of Non-Model Species?

The control of epidermal growth factor grafted on mesoporous silica nanoparticles for targeted delivery.

Mathematical approaches in estimating aptamer-target binding affinity.

Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review.

Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery.

Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells.

Novel Detection of Nasty Bugs, Prevention Is Better than Cure.

Aptamers: Cutting edge of cancer therapies.

Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.

Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer.

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof.

Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options.

Modelling of mass transport and distribution of aptamer in blood-brain barrier for tumour therapy and cancer treatment.